APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radioactive Stent Used for Cancer Treatments

Radioactive stent, the self-expanding stent with radioactivity particles is regards as very useful in the treatment of medium and advanced esophageal cancer.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radioactive stent, the self-expanding stent with radioactivity particles is regards as very useful in the treatment of medium and advanced esophageal cancer.

Selected research

Market Outlook & Growth Opportunities

Global Radioactive Stent Used for Cancer Treatments Market Outlook and Growth Opportunities 2026

25 December 2025195 pages

Choose your research edition.

Industry ResearchRadioactive Stent Used for Cancer Treatments Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Radioactive Stent Used for Cancer Treatments Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Radioactive Stent Used for Cancer Treatments Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radioactive Stent Used for Cancer Treatments Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Radioactive stent, the self-expanding stent with radioactivity particles is regards as very useful in the treatment of medium and advanced esophageal cancer.

The top 3 manufacturers are located therem Micro-Tech, Changzhou Zhiye and Changzhou Garson. They occupied market share above 88%.

This report provides an overview of the global Radioactive Stent Used for Cancer Treatments market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Radioactive Stent Used for Cancer Treatments and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radioactive Stent Used for Cancer Treatments sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radioactive Stent Used for Cancer Treatments market size, projected growth trends, production technologies, key applications, and end-use industries.

Radioactive Stent Used for Cancer Treatments Segment by Company

Micro-Tech

Changzhou Zhiye

Changzhou Garson

Radioactive Stent Used for Cancer Treatments Segment by Type

18mm Stent

20mm Stent

14mm Stent

Other Stents

Radioactive Stent Used for Cancer Treatments Segment by Application

Esophageal Cancer

Biliary Cancer

Others

Radioactive Stent Used for Cancer Treatments Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radioactive Stent Used for Cancer Treatments status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Radioactive Stent Used for Cancer Treatments market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radioactive Stent Used for Cancer Treatments significant trends, drivers, influence factors in global and regions.

6. To analyze Radioactive Stent Used for Cancer Treatments competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioactive Stent Used for Cancer Treatments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radioactive Stent Used for Cancer Treatments and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioactive Stent Used for Cancer Treatments.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radioactive Stent Used for Cancer Treatments market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radioactive Stent Used for Cancer Treatments industry.

Chapter 3: Detailed analysis of Radioactive Stent Used for Cancer Treatments manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Radioactive Stent Used for Cancer Treatments in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Radioactive Stent Used for Cancer Treatments in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radioactive Stent Used for Cancer Treatments Industry Trends Table 2. Radioactive Stent Used for Cancer Treatments Industry Drivers Table 3. Radioactive Stent Used for Cancer Treatments Industry Opportunities and Challenges Table 4. Radioactive Stent Used for Cancer Treatments Industry Restraints Table 5. Global Radioactive Stent Used for Cancer Treatments Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radioactive Stent Used for Cancer Treatments Revenue Share by Company (2021-2026) Table 7. Global Radioactive Stent Used for Cancer Treatments Sales Volume by Company (Units) & (2021-2026) Table 8. Global Radioactive Stent Used for Cancer Treatments Sales Volume Share by Company (2021-2026) Table 9. Global Radioactive Stent Used for Cancer Treatments Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Radioactive Stent Used for Cancer Treatments Company Ranking, (2024-2026) & (USD Million) Table 11. Global Radioactive Stent Used for Cancer Treatments Key Company Manufacturing Base & Headquarters Table 12. Global Radioactive Stent Used for Cancer Treatments Company, Product Type & Application Table 13. Global Radioactive Stent Used for Cancer Treatments Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Radioactive Stent Used for Cancer Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 18mm Stent Table 18. Significant Companies of 20mm Stent Table 19. Significant Companies of 14mm Stent Table 20. Significant Companies of Other Stents Table 21. Global Radioactive Stent Used for Cancer Treatments Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 22. Global Radioactive Stent Used for Cancer Treatments Sales Volume by Type (2021-2026) & (Units) Table 23. Global Radioactive Stent Used for Cancer Treatments Sales Volume by Type (2027-2032) & (Units) Table 24. Global Radioactive Stent Used for Cancer Treatments Sales Volume Share by Type (2021-2026) Table 25. Global Radioactive Stent Used for Cancer Treatments Sales Volume Share by Type (2027-2032) Table 26. Global Radioactive Stent Used for Cancer Treatments Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Radioactive Stent Used for Cancer Treatments Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Radioactive Stent Used for Cancer Treatments Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Type (2021-2026) Table 30. Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Esophageal Cancer Table 32. Significant Companies of Biliary Cancer Table 33. Significant Companies of Others Table 34. Global Radioactive Stent Used for Cancer Treatments Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Radioactive Stent Used for Cancer Treatments Sales Volume by Application (2021-2026) & (Units) Table 36. Global Radioactive Stent Used for Cancer Treatments Sales Volume by Application (2027-2032) & (Units) Table 37. Global Radioactive Stent Used for Cancer Treatments Sales Volume Share by Application (2021-2026) Table 38. Global Radioactive Stent Used for Cancer Treatments Sales Volume Share by Application (2027-2032) Table 39. Global Radioactive Stent Used for Cancer Treatments Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Radioactive Stent Used for Cancer Treatments Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Radioactive Stent Used for Cancer Treatments Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Application (2021-2026) Table 43. Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Application (2027-2032) Table 44. Global Radioactive Stent Used for Cancer Treatments Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Radioactive Stent Used for Cancer Treatments Sales by Region (2021-2026) & (Units) Table 46. Global Radioactive Stent Used for Cancer Treatments Sales Market Share by Region (2021-2026) Table 47. Global Radioactive Stent Used for Cancer Treatments Sales by Region (2027-2032) & (Units) Table 48. Global Radioactive Stent Used for Cancer Treatments Sales Market Share by Region (2027-2032) Table 49. Global Radioactive Stent Used for Cancer Treatments Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Radioactive Stent Used for Cancer Treatments Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Region (2021-2026) Table 52. Global Radioactive Stent Used for Cancer Treatments Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Region (2027-2032) Table 54. Global Radioactive Stent Used for Cancer Treatments Market Average Price (USD/Unit) by Region (2021-2026) Table 55. Global Radioactive Stent Used for Cancer Treatments Market Average Price (USD/Unit) by Region (2027-2032) Table 56. Global Radioactive Stent Used for Cancer Treatments Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Global Radioactive Stent Used for Cancer Treatments Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Radioactive Stent Used for Cancer Treatments Sales by Country (2021-2026) & (Units) Table 59. Global Radioactive Stent Used for Cancer Treatments Sales Market Share by Country (2021-2026) Table 60. Global Radioactive Stent Used for Cancer Treatments Sales by Country (2027-2032) & (Units) Table 61. Global Radioactive Stent Used for Cancer Treatments Sales Market Share by Country (2027-2032) Table 62. Global Radioactive Stent Used for Cancer Treatments Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Radioactive Stent Used for Cancer Treatments Sales Value Market Share by Country (2021-2026) Table 64. Global Radioactive Stent Used for Cancer Treatments Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Radioactive Stent Used for Cancer Treatments Sales Value Market Share by Country (2027-2032) Table 66. Micro-Tech Company Information Table 67. Micro-Tech Business Overview Table 68. Micro-Tech Radioactive Stent Used for Cancer Treatments Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Micro-Tech Radioactive Stent Used for Cancer Treatments Product Portfolio Table 70. Micro-Tech Recent Development Table 71. Changzhou Zhiye Company Information Table 72. Changzhou Zhiye Business Overview Table 73. Changzhou Zhiye Radioactive Stent Used for Cancer Treatments Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Changzhou Zhiye Radioactive Stent Used for Cancer Treatments Product Portfolio Table 75. Changzhou Zhiye Recent Development Table 76. Changzhou Garson Company Information Table 77. Changzhou Garson Business Overview Table 78. Changzhou Garson Radioactive Stent Used for Cancer Treatments Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Changzhou Garson Radioactive Stent Used for Cancer Treatments Product Portfolio Table 80. Changzhou Garson Recent Development Table 81. Key Raw Materials Table 82. Raw Materials Key Suppliers Table 83. Radioactive Stent Used for Cancer Treatments Distributors List Table 84. Radioactive Stent Used for Cancer Treatments Customers List Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Radioactive Stent Used for Cancer Treatments Product Image Figure 2. Global Radioactive Stent Used for Cancer Treatments Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032) & (US$ Million) Figure 4. Global Radioactive Stent Used for Cancer Treatments Sales (2021-2032) & (Units) Figure 5. Global Radioactive Stent Used for Cancer Treatments Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Radioactive Stent Used for Cancer Treatments Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 18mm Stent Image Figure 10. 20mm Stent Image Figure 11. 14mm Stent Image Figure 12. Other Stents Image Figure 13. Global Radioactive Stent Used for Cancer Treatments Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Radioactive Stent Used for Cancer Treatments Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Radioactive Stent Used for Cancer Treatments Sales Volume Share by Type (2021-2032) Figure 16. Global Radioactive Stent Used for Cancer Treatments Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Radioactive Stent Used for Cancer Treatments Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Type (2021-2032) Figure 19. Esophageal Cancer Image Figure 20. Biliary Cancer Image Figure 21. Others Image Figure 22. Global Radioactive Stent Used for Cancer Treatments Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Radioactive Stent Used for Cancer Treatments Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Radioactive Stent Used for Cancer Treatments Sales Volume Share by Application (2021-2032) Figure 25. Global Radioactive Stent Used for Cancer Treatments Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Radioactive Stent Used for Cancer Treatments Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Application (2021-2032) Figure 28. Global Radioactive Stent Used for Cancer Treatments Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 29. Global Radioactive Stent Used for Cancer Treatments Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Radioactive Stent Used for Cancer Treatments Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032) & (US$ Million) Figure 33. North America Radioactive Stent Used for Cancer Treatments Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Radioactive Stent Used for Cancer Treatments Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Radioactive Stent Used for Cancer Treatments Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032) & (US$ Million) Figure 39. South America Radioactive Stent Used for Cancer Treatments Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Radioactive Stent Used for Cancer Treatments Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Radioactive Stent Used for Cancer Treatments Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Radioactive Stent Used for Cancer Treatments Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 18mm Stent
  • 20mm Stent
  • 14mm Stent
  • Other Stents
Applications
  • Esophageal Cancer
  • Biliary Cancer
  • Others
Companies covered
  • Micro-Tech
  • Changzhou Zhiye
  • Changzhou Garson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032)
  4. 1.2.2 Global Radioactive Stent Used for Cancer Treatments Sales Volume (2021-2032)
  5. 1.2.3 Global Radioactive Stent Used for Cancer Treatments Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Radioactive Stent Used for Cancer Treatments Market Dynamics
  1. 2.1 Radioactive Stent Used for Cancer Treatments Industry Trends
  2. 2.2 Radioactive Stent Used for Cancer Treatments Industry Drivers
  3. 2.3 Radioactive Stent Used for Cancer Treatments Industry Opportunities and Challenges
  4. 2.4 Radioactive Stent Used for Cancer Treatments Industry Restraints
3 Radioactive Stent Used for Cancer Treatments Market by Company
  1. 3.1 Global Radioactive Stent Used for Cancer Treatments Company Revenue Ranking in 2025
  2. 3.2 Global Radioactive Stent Used for Cancer Treatments Revenue by Company (2021-2026)
  3. 3.3 Global Radioactive Stent Used for Cancer Treatments Sales Volume by Company (2021-2026)
  4. 3.4 Global Radioactive Stent Used for Cancer Treatments Average Price by Company (2021-2026)
  5. 3.5 Global Radioactive Stent Used for Cancer Treatments Company Ranking (2024-2026)
  6. 3.6 Global Radioactive Stent Used for Cancer Treatments Company Manufacturing Base and Headquarters
  7. 3.7 Global Radioactive Stent Used for Cancer Treatments Company Product Type and Application
  8. 3.8 Global Radioactive Stent Used for Cancer Treatments Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Radioactive Stent Used for Cancer Treatments Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Radioactive Stent Used for Cancer Treatments Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Radioactive Stent Used for Cancer Treatments Market by Type
  1. 4.1 Radioactive Stent Used for Cancer Treatments Type Introduction
  2. 4.1.1 18mm Stent
  3. 4.1.2 20mm Stent
  4. 4.1.3 14mm Stent
  5. 4.1.4 Other Stents
  6. 4.2 Global Radioactive Stent Used for Cancer Treatments Sales Volume by Type
  7. 4.2.1 Global Radioactive Stent Used for Cancer Treatments Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Radioactive Stent Used for Cancer Treatments Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Radioactive Stent Used for Cancer Treatments Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Radioactive Stent Used for Cancer Treatments Sales Value by Type
  11. 4.3.1 Global Radioactive Stent Used for Cancer Treatments Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Radioactive Stent Used for Cancer Treatments Sales Value by Type (2021-2032)
  13. 4.3.3 Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Type (2021-2032)
5 Radioactive Stent Used for Cancer Treatments Market by Application
  1. 5.1 Radioactive Stent Used for Cancer Treatments Application Introduction
  2. 5.1.1 Esophageal Cancer
  3. 5.1.2 Biliary Cancer
  4. 5.1.3 Others
  5. 5.2 Global Radioactive Stent Used for Cancer Treatments Sales Volume by Application
  6. 5.2.1 Global Radioactive Stent Used for Cancer Treatments Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radioactive Stent Used for Cancer Treatments Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Radioactive Stent Used for Cancer Treatments Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Radioactive Stent Used for Cancer Treatments Sales Value by Application
  10. 5.3.1 Global Radioactive Stent Used for Cancer Treatments Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Radioactive Stent Used for Cancer Treatments Sales Value by Application (2021-2032)
  12. 5.3.3 Global Radioactive Stent Used for Cancer Treatments Sales Value Share by Application (2021-2032)
6 Radioactive Stent Used for Cancer Treatments Regional Sales and Value Analysis
  1. 6.1 Global Radioactive Stent Used for Cancer Treatments Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radioactive Stent Used for Cancer Treatments Sales by Region (2021-2032)
  3. 6.2.1 Global Radioactive Stent Used for Cancer Treatments Sales by Region: 2021-2026
  4. 6.2.2 Global Radioactive Stent Used for Cancer Treatments Sales by Region (2027-2032)
  5. 6.3 Global Radioactive Stent Used for Cancer Treatments Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Radioactive Stent Used for Cancer Treatments Sales Value by Region (2021-2032)
  7. 6.4.1 Global Radioactive Stent Used for Cancer Treatments Sales Value by Region: 2021-2026
  8. 6.4.2 Global Radioactive Stent Used for Cancer Treatments Sales Value by Region (2027-2032)
  9. 6.5 Global Radioactive Stent Used for Cancer Treatments Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032)
  12. 6.6.2 North America Radioactive Stent Used for Cancer Treatments Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032)
  15. 6.7.2 Europe Radioactive Stent Used for Cancer Treatments Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Radioactive Stent Used for Cancer Treatments Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032)
  21. 6.9.2 South America Radioactive Stent Used for Cancer Treatments Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Radioactive Stent Used for Cancer Treatments Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Radioactive Stent Used for Cancer Treatments Sales Value Share by Country, 2025 VS 2032
7 Radioactive Stent Used for Cancer Treatments Country-level Sales and Value Analysis
  1. 7.1 Global Radioactive Stent Used for Cancer Treatments Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radioactive Stent Used for Cancer Treatments Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Radioactive Stent Used for Cancer Treatments Sales by Country (2021-2032)
  4. 7.3.1 Global Radioactive Stent Used for Cancer Treatments Sales by Country (2021-2026)
  5. 7.3.2 Global Radioactive Stent Used for Cancer Treatments Sales by Country (2027-2032)
  6. 7.4 Global Radioactive Stent Used for Cancer Treatments Sales Value by Country (2021-2032)
  7. 7.4.1 Global Radioactive Stent Used for Cancer Treatments Sales Value by Country (2021-2026)
  8. 7.4.2 Global Radioactive Stent Used for Cancer Treatments Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Radioactive Stent Used for Cancer Treatments Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Radioactive Stent Used for Cancer Treatments Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Radioactive Stent Used for Cancer Treatments Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Micro-Tech
  2. 8.1.1 Micro-Tech Company Information
  3. 8.1.2 Micro-Tech Business Overview
  4. 8.1.3 Micro-Tech Radioactive Stent Used for Cancer Treatments Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Micro-Tech Radioactive Stent Used for Cancer Treatments Product Portfolio
  6. 8.1.5 Micro-Tech Recent Developments
  7. 8.2 Changzhou Zhiye
  8. 8.2.1 Changzhou Zhiye Company Information
  9. 8.2.2 Changzhou Zhiye Business Overview
  10. 8.2.3 Changzhou Zhiye Radioactive Stent Used for Cancer Treatments Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Changzhou Zhiye Radioactive Stent Used for Cancer Treatments Product Portfolio
  12. 8.2.5 Changzhou Zhiye Recent Developments
  13. 8.3 Changzhou Garson
  14. 8.3.1 Changzhou Garson Company Information
  15. 8.3.2 Changzhou Garson Business Overview
  16. 8.3.3 Changzhou Garson Radioactive Stent Used for Cancer Treatments Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Changzhou Garson Radioactive Stent Used for Cancer Treatments Product Portfolio
  18. 8.3.5 Changzhou Garson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radioactive Stent Used for Cancer Treatments Value Chain Analysis
  2. 9.1.1 Radioactive Stent Used for Cancer Treatments Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radioactive Stent Used for Cancer Treatments Sales Mode & Process
  6. 9.2 Radioactive Stent Used for Cancer Treatments Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radioactive Stent Used for Cancer Treatments Distributors
  9. 9.2.3 Radioactive Stent Used for Cancer Treatments Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst